GCPII prevents neuroprotectiveactivity of NAAG by its cleavage1 and ishighly expressed in prostate cancer,37 andhence, it represents a valuable target with diagnostic and therapeuticpotentials. The gene discussed is FOLH1; the disease is prostate carcinoma.